logo
Implied Volatility Surging for American Electric Power Stock Options

Implied Volatility Surging for American Electric Power Stock Options

Yahoo10-07-2025
Investors in American Electric Power Company, Inc. AEP need to pay close attention to the stock based on moves in the options market lately. That is because the Jul 18, 2025 $135 Call had some of the highest implied volatility of all equity options today.
Implied volatility shows how much movement the market is expecting in the future. Options with high levels of implied volatility suggest that investors in the underlying stocks are expecting a big move in one direction or the other. It could also mean there is an event coming up soon that may cause a big rally or a huge sell-off. However, implied volatility is only one piece of the puzzle when putting together an options trading strategy.
Clearly, options traders are pricing in a big move for American Electric Power shares, but what is the fundamental picture for the company? Currently, American Electric Power is a Zacks Rank #3 (Hold) in the Utility - Electric Power industry that ranks in the Top 33% of our Zacks Industry Rank. Over the last 30 days, the Zacks Consensus Estimate for the current quarter has moved from $1.25 per share to $1.23 in that period.Given the way analysts feel about American Electric Power right now, this huge implied volatility could mean there's a trade developing. Oftentimes, options traders look for options with high levels of implied volatility to sell premium. This is a strategy many seasoned traders use because it captures decay. At expiration, the hope for these traders is that the underlying stock does not move as much as originally expected.
Check out the simple yet high-powered approach that Zacks Executive VP Kevin Matras has used to close recent double and triple-digit winners. In addition to impressive profit potential, these trades can actually reduce your risk.Click to see the trades now >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
American Electric Power Company, Inc. (AEP) : Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Brokers Suggest Investing in Bit Digital (BTBT): Read This Before Placing a Bet
Brokers Suggest Investing in Bit Digital (BTBT): Read This Before Placing a Bet

Yahoo

time41 minutes ago

  • Yahoo

Brokers Suggest Investing in Bit Digital (BTBT): Read This Before Placing a Bet

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter? Before we discuss the reliability of brokerage recommendations and how to use them to your advantage, let's see what these Wall Street heavyweights think about Bit Digital, Inc. (BTBT). Bit Digital currently has an average brokerage recommendation (ABR) of 1.00, on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell, etc.) made by five brokerage firms. An ABR of 1.00 indicates Strong Buy. Of the five recommendations that derive the current ABR, five are Strong Buy, representing 100% of all recommendations. Brokerage Recommendation Trends for BTBT Check price target & stock forecast for Bit Digital here>>> While the ABR calls for buying Bit Digital, it may not be wise to make an investment decision solely based on this information. Several studies have shown limited to no success of brokerage recommendations in guiding investors to pick stocks with the best price increase potential. Do you wonder why? As a result of the vested interest of brokerage firms in a stock they cover, their analysts tend to rate it with a strong positive bias. According to our research, brokerage firms assign five "Strong Buy" recommendations for every "Strong Sell" recommendation. In other words, their interests aren't always aligned with retail investors, rarely indicating where the price of a stock could actually be heading. Therefore, the best use of this information could be validating your own research or an indicator that has proven to be highly successful in predicting a stock's price movement. Zacks Rank, our proprietary stock rating tool with an impressive externally audited track record, categorizes stocks into five groups, ranging from Zacks Rank #1 (Strong Buy) to Zacks Rank #5 (Strong Sell), and is an effective indicator of a stock's price performance in the near future. Therefore, using the ABR to validate the Zacks Rank could be an efficient way of making a profitable investment decision. Zacks Rank Should Not Be Confused With ABR Although both Zacks Rank and ABR are displayed in a range of 1--5, they are different measures altogether. The ABR is calculated solely based on brokerage recommendations and is typically displayed with decimals (example: 1.28). In contrast, the Zacks Rank is a quantitative model allowing investors to harness the power of earnings estimate revisions. It is displayed in whole numbers -- 1 to 5. It has been and continues to be the case that analysts employed by brokerage firms are overly optimistic with their recommendations. Because of their employers' vested interests, these analysts issue more favorable ratings than their research would support, misguiding investors far more often than helping them. On the other hand, earnings estimate revisions are at the core of the Zacks Rank. And empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements. In addition, the different Zacks Rank grades are applied proportionately to all stocks for which brokerage analysts provide current-year earnings estimates. In other words, this tool always maintains a balance among its five ranks. Another key difference between the ABR and Zacks Rank is freshness. The ABR is not necessarily up-to-date when you look at it. But, since brokerage analysts keep revising their earnings estimates to account for a company's changing business trends, and their actions get reflected in the Zacks Rank quickly enough, it is always timely in indicating future price movements. Should You Invest in BTBT? In terms of earnings estimate revisions for Bit Digital, the Zacks Consensus Estimate for the current year has declined 90% over the past month to -$0.32. Analysts' growing pessimism over the company's earnings prospects, as indicated by strong agreement among them in revising EPS estimates lower, could be a legitimate reason for the stock to plunge in the near term. The size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, has resulted in a Zacks Rank #4 (Sell) for Bit Digital. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> Therefore, it could be wise to take the Buy-equivalent ABR for Bit Digital with a grain of salt. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Bit Digital, Inc. (BTBT) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research

Are Medical Stocks Lagging Abbott Laboratories (ABT) This Year?
Are Medical Stocks Lagging Abbott Laboratories (ABT) This Year?

Yahoo

time2 hours ago

  • Yahoo

Are Medical Stocks Lagging Abbott Laboratories (ABT) This Year?

Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Abbott (ABT) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? A quick glance at the company's year-to-date performance in comparison to the rest of the Medical sector should help us answer this question. Abbott is one of 985 companies in the Medical group. The Medical group currently sits at #8 within the Zacks Sector Rank. The Zacks Sector Rank gauges the strength of our 16 individual sector groups by measuring the average Zacks Rank of the individual stocks within the groups. The Zacks Rank is a proven model that highlights a variety of stocks with the right characteristics to outperform the market over the next one to three months. The system emphasizes earnings estimate revisions and favors companies with improving earnings outlooks. Abbott is currently sporting a Zacks Rank of #2 (Buy). Within the past quarter, the Zacks Consensus Estimate for ABT's full-year earnings has moved 0% higher. This signals that analyst sentiment is improving and the stock's earnings outlook is more positive. According to our latest data, ABT has moved about 6.5% on a year-to-date basis. Meanwhile, the Medical sector has returned an average of -5.7% on a year-to-date basis. This means that Abbott is outperforming the sector as a whole this year. One other Medical stock that has outperformed the sector so far this year is Astellas Pharma Inc. (ALPMY). The stock is up 0.7% year-to-date. For Astellas Pharma Inc., the consensus EPS estimate for the current year has increased 13.5% over the past three months. The stock currently has a Zacks Rank #2 (Buy). Looking more specifically, Abbott belongs to the Medical - Products industry, a group that includes 84 individual stocks and currently sits at #169 in the Zacks Industry Rank. Stocks in this group have gained about 3% so far this year, so ABT is performing better this group in terms of year-to-date returns. In contrast, Astellas Pharma Inc. falls under the Medical - Drugs industry. Currently, this industry has 155 stocks and is ranked #86. Since the beginning of the year, the industry has moved +6.6%. Abbott and Astellas Pharma Inc. could continue their solid performance, so investors interested in Medical stocks should continue to pay close attention to these stocks. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Abbott Laboratories (ABT) : Free Stock Analysis Report Astellas Pharma Inc. (ALPMY) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research

Mastercard Incorporated (MA) is Attracting Investor Attention: Here is What You Should Know
Mastercard Incorporated (MA) is Attracting Investor Attention: Here is What You Should Know

Yahoo

time2 hours ago

  • Yahoo

Mastercard Incorporated (MA) is Attracting Investor Attention: Here is What You Should Know

MasterCard (MA) has been one of the most searched-for stocks on lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term. Over the past month, shares of this processor of debit and credit card payments have returned +3.1%, compared to the Zacks S&P 500 composite's +5.4% change. During this period, the Zacks Financial Transaction Services industry, which MasterCard falls in, has lost 1.1%. The key question now is: What could be the stock's future direction? Although media reports or rumors about a significant change in a company's business prospects usually cause its stock to trend and lead to an immediate price change, there are always certain fundamental factors that ultimately drive the buy-and-hold decision. Earnings Estimate Revisions Here at Zacks, we prioritize appraising the change in the projection of a company's future earnings over anything else. That's because we believe the present value of its future stream of earnings is what determines the fair value for its stock. Our analysis is essentially based on how sell-side analysts covering the stock are revising their earnings estimates to take the latest business trends into account. When earnings estimates for a company go up, the fair value for its stock goes up as well. And when a stock's fair value is higher than its current market price, investors tend to buy the stock, resulting in its price moving upward. Because of this, empirical studies indicate a strong correlation between trends in earnings estimate revisions and short-term stock price movements. For the current quarter, MasterCard is expected to post earnings of $4.06 per share, indicating a change of +13.1% from the year-ago quarter. The Zacks Consensus Estimate has changed +0.6% over the last 30 days. For the current fiscal year, the consensus earnings estimate of $16.04 points to a change of +9.9% from the prior year. Over the last 30 days, this estimate has changed +0.4%. For the next fiscal year, the consensus earnings estimate of $18.72 indicates a change of +16.7% from what MasterCard is expected to report a year ago. Over the past month, the estimate has changed +0.4%. With an impressive externally audited track record, our proprietary stock rating tool -- the Zacks Rank -- is a more conclusive indicator of a stock's near-term price performance, as it effectively harnesses the power of earnings estimate revisions. The size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, has resulted in a Zacks Rank #2 (Buy) for MasterCard. The chart below shows the evolution of the company's forward 12-month consensus EPS estimate: 12 Month EPS Revenue Growth Forecast Even though a company's earnings growth is arguably the best indicator of its financial health, nothing much happens if it cannot raise its revenues. It's almost impossible for a company to grow its earnings without growing its revenue for long periods. Therefore, knowing a company's potential revenue growth is crucial. In the case of MasterCard, the consensus sales estimate of $7.99 billion for the current quarter points to a year-over-year change of +14.9%. The $31.96 billion and $35.85 billion estimates for the current and next fiscal years indicate changes of +13.5% and +12.1%, respectively. Last Reported Results and Surprise History MasterCard reported revenues of $7.25 billion in the last reported quarter, representing a year-over-year change of +14.2%. EPS of $3.73 for the same period compares with $3.31 a year ago. Compared to the Zacks Consensus Estimate of $7.12 billion, the reported revenues represent a surprise of +1.81%. The EPS surprise was +4.48%. The company beat consensus EPS estimates in each of the trailing four quarters. The company topped consensus revenue estimates each time over this period. Valuation Without considering a stock's valuation, no investment decision can be efficient. In predicting a stock's future price performance, it's crucial to determine whether its current price correctly reflects the intrinsic value of the underlying business and the company's growth prospects. While comparing the current values of a company's valuation multiples, such as price-to-earnings (P/E), price-to-sales (P/S), and price-to-cash flow (P/CF), with its own historical values helps determine whether its stock is fairly valued, overvalued, or undervalued, comparing the company relative to its peers on these parameters gives a good sense of the reasonability of the stock's price. The Zacks Value Style Score (part of the Zacks Style Scores system), which pays close attention to both traditional and unconventional valuation metrics to grade stocks from A to F (an A is better than a B; a B is better than a C; and so on), is pretty helpful in identifying whether a stock is overvalued, rightly valued, or temporarily undervalued. MasterCard is graded D on this front, indicating that it is trading at a premium to its peers. Click here to see the values of some of the valuation metrics that have driven this grade. Conclusion The facts discussed here and much other information on might help determine whether or not it's worthwhile paying attention to the market buzz about MasterCard. However, its Zacks Rank #2 does suggest that it may outperform the broader market in the near term. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Mastercard Incorporated (MA) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store